A recent study indicated that CysC at 24 h is the most effective biomarker for diagnosing CIN, although baseline levels of other prevalent biomarkers, including serum IL-18, β-2M, and TNFα, are the most reliable prognostic indicators [39]. This evidence concerns the gene IL18 and cervical squamous intraepithelial neoplasia.